Related Experiment Videos
Vancomycin-associated leukocytoclastic vasculitis
Makhawadee Pongruangporn1, David J Ritchie, Dongsi Lu
1Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
Abstract:
Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis.
Insights
Vancomycin can cause leukocytoclastic vasculitis, a rare skin reaction. This case highlights the importance of considering drug-induced vasculitis in patients presenting with purpura after vancomycin treatment.
Area of Science:
- Pharmacology
- Dermatology
- Pathology
Background:
- Vancomycin is a critical antibiotic for treating serious infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Adverse reactions to vancomycin are monitored, but specific cutaneous manifestations like leukocytoclastic vasculitis are infrequently reported.
- Understanding the full spectrum of vancomycin's side effects is crucial for patient safety and effective treatment.
Observation:
- A patient developed itching and palpable purpura on their lower extremities after a six-day course of intravenous vancomycin.
- The clinical presentation suggested a potential drug-induced hypersensitivity reaction.
- Diagnostic evaluation was initiated to determine the etiology of the cutaneous lesions.
Findings:
- Skin biopsy confirmed the presence of leukocytoclastic vasculitis.
- This histological finding directly linked the patient's symptoms to a specific inflammatory process in the blood vessels.
- The temporal association with vancomycin administration strongly implicates the antibiotic as the causative agent.
Implications:
- This case adds to the limited literature on vancomycin-induced leukocytoclastic vasculitis.
- Clinicians should maintain a high index of suspicion for drug-induced vasculitis in patients with similar presentations.
- Early recognition and discontinuation of the offending agent are essential for managing this adverse drug reaction.
Related Concept Videos
Cytotoxic Edema: Pathophysiology
Hypersensitivity Reactions: Cytolytic Reactions
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cytomegalovirus Disease
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis II: Clinical Features of Infective Endocarditis